| Clinical data | |
|---|---|
| Trade names | Rondimen, Pondinil, Anexate |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.037.511 |
| Chemical and physical data | |
| Formula | C12H18ClN |
| Molar mass | 211.73 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Mefenorex (marketed asRondimen,Pondinil,Anexate) is anamphetamine derivative with a relatively mildpsychostimulant profile. Developed in the 1960s, it was used throughout the 1970s as anappetite suppressant for treatingobesity.[2][3] Mefenorex is aprodrug ofamphetamine; upon ingestion, the compound will begin to metabolize into, as well as promote the production of, theactive metaboliteslevoamphetamine anddextroamphetamine.[4] Multiple sources have noted the substance as exerting "mild stimulant effects....[and having] relatively little abuse potential."[5]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |